CO105 Long-Term Benefit of Ataluren Treatment in Non-Sense Duchenne Muscular Dystrophy Versus Standard of Care
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.184
https://www.valueinhealthjournal.com/article/S1098-3015(22)02388-9/fulltext
Title :
CO105 Long-Term Benefit of Ataluren Treatment in Non-Sense Duchenne Muscular Dystrophy Versus Standard of Care
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02388-9&doi=10.1016/j.jval.2022.09.184
First page :
Section Title :
Open access? :
No
Section Order :
11439